SIGN-UP NOW! SIGN-UP NOW! Click to become a VoiceAmerica Member for Free!
Voiceamerica radio logo
voiceamerica-health-and-wellness radio logo
Apple logo Google Play Store Kindle store
C. diff. Spores and More
top banner

C. diff. Spores and More

Tuesday at 10 AM Pacific

October 10th 2017:Encore: C. difficile Prevention: Evaluating the Role of Vaccines

Richard Haupt, MD, Vice President, Medical Development Scientific & Clinical Affairs, at Pfizer where he serves as the global franchise lead for pipeline vaccines and Kathrin U. Jansen, PhD, Senior Vice President and head of Vaccine Research and Development at Pfizer Inc and Chris Webber, MD, Senior Director, Vaccines Clinical Research and Development. Dr. Webber is clinical program lead of the recently acquired meningococcal ACWY program from GSK, and is the clinical program lead for Pfizer’s Clostridium difficile vaccine. Our discussion will be focused on C. difficile Prevention: Evaluating

Read more
Share Email SHARE
Download PDF DOWNLOAD PDF
Get Code GET CODE

Tune in

Tuesday at 10 AM Pacific Time on VoiceAmerica Health and Wellness Channel
LISTEN LIVE
EPISODE ON DEMAND
VIEW HOST PAGE
Questions? Comments?
Call In Live!
Toll Free: 1-866-472-5792
Intl: 001-480-553-5759

Featured Guests

Guest Image

Dr. Kathrin U. Jansen, Ph.D.

Kathrin U. Jansen, Ph.D., is the Senior Vice President and Head of Vaccine Research and Development (VRD) at Pfizer Inc, and a member of Pfizer's Worldwide Research and Development leadership team. Dr. Jansen leads a fully integrated, global vaccines research and development organization, with responsibilities ranging from discovery to registration and post-marketing commitments and a clinical vaccines portfolio that includes vaccines to prevent or treat diseases of significant unmet medical need such as Staphylococcus aureus, Clostridium difficile, Group B stretococcus and prostate cancer. More recent accomplishments are the global licensures of Prev(e)nar13 ® to prevent pneumococcal d
Read more
Guest Image

Chris Webber, MD

Chris Webber obtained his medical degree at the University of the Witwatersrand in Johannesburg, South Africa, and worked in trauma and then in family practice in the Johannesburg area. In 1997, he transitioned into the pharmaceutical industry and joined Quintiles in South Africa where he became Medical Director. He spent 7 years in Quintiles where he was medically responsible for all studies across most therapeutic areas, as well as for Business Development, Regulatory Affairs, Medical Affairs Contracting and Pharmacovigilance.In 2005, Dr Webber joined Wyeth, South Africa where he started up the Clinical Research and Development operations in the Johannesburg office. He is Senior Directo
Read more
Guest Image

Richard Haupt MD

Richard. Haupt, MD holds a BS in Zoology from the University of Maryland, an MD from Harvard Medical School and an MPH from the Johns Hopkins Bloomberg School of Public Health. He completed his Residency and Chief Residency at the Children’s Hospital of Philadelphia in 1987. He practiced general pediatric medicine for 15 years in a large academic pediatric practice outside Philadelphia where he also participated as an investigator in vaccine clinical trials. Dr. Haupt is currently Vice President, Medical Development Scientific & Clinical Affairs, at Pfizer where he serves as the global franchise lead for pipeline vaccines. In previous industry roles, he served as Head of Pediatric Medi
Read more

Share This Episode

facebook Share On Facebook
twitter Share On Twitter
Linkedin Share On LinkedIn
Share Email Share this E-mail
https://www.voiceamerica.com/show/2441/c-diff-spores-and-more 28/11/2017 10:00 28/11/2017 11:00 C. diff. Spores and More https://www.voiceamerica.com/show/2441/c-diff-spores-and-more Richard Haupt, MD, Vice President, Medical Development Scientific & Clinical Affairs, at Pfizer where he serves as the global franchise lead for pipeline vaccines and Kathrin U. Jansen, PhD, Senior Vice President and head of Vaccine Research and Development at Pfizer Inc and Chris Webber, MD, Senior Director, Vaccines Clinical Research and Development. Dr. Webber is clinical program lead of the recently acquired meningococcal ACWY program from GSK, and is the clinical program lead for Pfizer’s Clostridium difficile vaccine. Our discussion will be focused on C. difficile Prevention: Evaluating the Role of Vaccines. VoiceAmerica | Talk Radio | Online Talk Radio studio@voiceamerica.com false DD/MM/YYYY Add to Calendar
Email Host Email the Host

Connect with VoiceAmerica

Download our mobile apps
App store Google play Blackberry store
GPlus Facebook Twitter Linkedin Social Media
presspass-banner